December 26, 2019

Future of Due Diligence in Healthcare M&A

December, 2019

Large corporate mergers and spin-offs, biotech and technology breakthroughs, and stronger-than-ever data privacy requirements make the healthcare sector one rich with opportunity and risk. That means staying on top of due diligence best practices has never been more important.

The good news is that innovative trends are accelerating due diligence across all industries.

Download our latest whitepaper now to explore:

  • Distinct challenges facing the healthcare industry
  • Key factors driving new due diligence trends
  • Extensive polling and survey results from industry peers and leaders
  • Technology advances to ease the due diligence challenge

You may also like:

Datasite Forecaster September Global Outlook

We've all seen the M&A numbers on publicly announced deals. But what's going on beneath the surface? Take a look at our latest report, based on aggregated and anonymized global M&A deal activity on Datasite's platform.

M & A Professional Holding an Umbrella
Deal Drivers: APAC HY 2022

M&A activity across APAC has proven remarkably resilient in the first half of 2022 despite strong headwinds. Read our latest report to learn more about the regions and sectors that drove dealmaking in H1 2022, including the latest heat chart, league tables, and top bidders by value and volume.

Deal Drivers: AMERS HY 2022

Although overall M&A activity has slowed in 2022, the slight deceleration is a mean reversion after an unsustainably busy period. In Deal Drivers: Americas HY 2022 we bring you the highlights and insights from the first half of 2022.

Overhead view of San Francisco